Biocentis
PrivateLast Round
Grant
Nov 19, 2025
Total Funding Raised
$6.91M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biocentis is a biotechnology company that develops next-generation genetic technologies and AI-driven solutions for sustainable insect control to protect public health, agriculture, and biodiversity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biocentis Comparables
Compare Biocentis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synvect | 81% | |
| MosquitoMate, Inc. | 79% | |
| Agragene Inc | 79% |
Biocentis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 19, 2025 | ||||
| Grant | Nov 27, 2023 | ||||
| Grant | Oct 14, 2023 | ||||
| Pre Seed | Feb 1, 2023 |
Biocentis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Neurone | Grant, Pre Seed |
| Corbites | Grant |
| The Grantham Foundation for the Protection of the Environment | Grant |
| Jeremy and Hannelore Grantham Environmental Trust | Grant |
| Italian Ministry of University and Research | Grant |
| Novaterra | Grant |
| Algebris Investments | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 19, 2025
$19M raised in Seed round.
- Oct 14, 2023
$445K grant round completed.
Biocentis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biocentis's valuation, stock price, and market status.
Is Biocentis a public or private company?
Biocentis is a private company.
What is the current stock price of Biocentis?
Biocentis is a private company with no public stock price. No recent secondary market data is available.
How much is Biocentis worth (valuation)?
Valuation information for Biocentis is not publicly available.
Can I buy Biocentis stock?
Biocentis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biocentis's last funding round?
Biocentis's most recent funding round was Seed on November 19, 2025.
Who are the main investors in Biocentis?
Key investors in Biocentis include The Grantham Foundation for the Protection of the Environment, Algebris Investments.
Will Biocentis IPO soon?
No public IPO plans have been announced for Biocentis.
How can I track Biocentis secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biocentis's secondary market activity and sign up for updates.